NCT06585410 2026-04-08
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Recruiting
Regeneron Pharmaceuticals
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Ankyra Therapeutics, Inc
OncoNano Medicine, Inc.